Relay Therapeutics gets US FDA Breakthrough Therapy Designation for zovegalisib to treat advanced breast cancer: Cambridge, Massachusetts Thursday, February 5, 2026, 16:00 Hrs [IS ...
In 2025 alone, the agency issued over 50 oncology approvals [1], but the real story is the aggressive pivot toward targeted therapies for high-unmet-need solid tumors. That momentum has accelerated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results